Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Icon plc (ICLR)
NASDAQ:ICLR
Holding ICLR?
Track your performance easily
ICLR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$183.38 - $347.72
Previous CloseN/A
Volume330.38K
Average Volume (3M)976.67K
Market Cap
$16.72B
Enterprise Value$26.86B
Total Cash (Recent Filing)$260.59M
Total Debt (Recent Filing)$348.51M
Price to Earnings (P/E)22.1
Beta1.27
Next Earnings
Feb 19, 2025EPS Estimate
3.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.98
Shares Outstanding82,559,364
10 Day Avg. Volume1,107,196
30 Day Avg. Volume976,675
Standard Deviation0.10
R-Squared0.43
Alpha-0.00581
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.06
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.61
Enterprise Value/Revenue6.93
Enterprise Value/Gross Profit11.19
Enterprise Value/Ebitda37.88
Forecast
1Y Price Target
$267.27Price Target Upside34.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
Icon News
PremiumCompany Announcements
ICON plc Announces 2025 Financial Guidance Amid Market Challenges
PremiumCompany Announcements
ICON plc to Present at the J.P. Morgan Healthcare ConferenceBulls Say, Bears Say
Bulls Say
Cost ManagementICLR management is swiftly deploying cost-saving actions in response to lower expected activity, which is expected to improve EBITDA margin year over year.
Market ValuationICLR's current valuation is perceived as oversold, prompting a near-term positive trading call.
Strategic PartnershipsICLR has signed 4 new large pharma partnerships since the merger, with the potential for significant revenue growth.
Bears Say
Financial GuidanceThe initial FY25 outlook is still well below street sales and EPS estimates of $8.50bn and $14.83, respectively.
Revenue ChallengesRevenue was impacted by an uptick in vaccine cancellations and lower COVID trials.
Sector PerformanceDespite the interest in ICLR, the overall outlook for the CRO sector remains unconstructive, with sector performance worsening and old growth paradigms possibly outdated.
---
Ownership Overview
1.96% Insiders
29.87% Mutual Funds
2.31% Other Institutional Investors
64.68% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ICLR FAQ
What was Icon plc’s price range in the past 12 months?
Icon plc lowest stock price was $183.38 and its highest was $347.72 in the past 12 months.
What is Icon plc’s market cap?
Icon plc’s market cap is $16.72B.
When is Icon plc’s upcoming earnings report date?
Icon plc’s upcoming earnings report date is Feb 19, 2025 which is in 28 days.
How were Icon plc’s earnings last quarter?
Icon plc released its earnings results on Oct 23, 2024. The company reported $3.35 earnings per share for the quarter, missing the consensus estimate of $3.851 by -$0.501.
Is Icon plc overvalued?
According to Wall Street analysts Icon plc’s price is currently Undervalued.
Does Icon plc pay dividends?
Icon plc does not currently pay dividends.
What is Icon plc’s EPS estimate?
Icon plc’s EPS estimate is 3.43.
How many shares outstanding does Icon plc have?
Icon plc has 82,559,364 shares outstanding.
What happened to Icon plc’s price movement after its last earnings report?
Icon plc reported an EPS of $3.35 in its last earnings report, missing expectations of $3.851. Following the earnings report the stock price went down -21.025%.
Which hedge fund is a major shareholder of Icon plc?
Currently, no hedge funds are holding shares in ICLR
---
Icon Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$267.27 (34.91% Upside)
$267.27 (34.91% Upside)
Blogger Sentiment
Bullish
ICLR Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 160.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 10.1%
Last 30 Days ▲ 10.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.06%
12-Months-Change
Fundamentals
Return on Equity
7.98%
Trailing 12-Months
Asset Growth
1.05%
Trailing 12-Months
Company Description
Icon plc
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
---
ICLR Company Deck
---
ICLR Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While ICON achieved significant strategic partnerships and growth in specific therapeutic areas, it faced challenges with revenue expectations, delays in the biotech segment, and substantial cancellations. Despite these setbacks, the company remains optimistic about future growth, supported by a strong backlog and strategic capital deployment.Read More>---
ICLR Stock 12 Month Forecast
Average Price Target
$267.27
▲(34.91% Upside)
Technical Analysis
Medpace Holdings
―
IQVIA Holdings
―
West Pharmaceutical Services
―
QuidelOrtho
―
Charles River Labs
―
Quanterix
―
Best Analysts Covering ICLR
1 Year
1 Year Success Rate
21/31 ratings generated profit
1 Year Average Return
+6.23%
reiterated a buy rating last month
Copying Ann Hynes's trades and holding each position for 1 Year would result in 67.74% of your transactions generating a profit, with an average return of +6.23% per trade.
---